Teoxane Laboratories
Krishna Sai is a seasoned professional with extensive experience in the pharmaceutical and medical aesthetics industry. Currently serving as the US Alliance Lead at Teoxane Laboratories since April 2022, Krishna has held various leadership roles at Teoxane Asia Pacific Pte Ltd as Vice President for the APAC region and General Manager for ANZ since May 2019. Previous positions include Vice President for Asia at Teoxane Laboratories, Business Unit Director for Medical Aesthetics at Allergan Australia, and Managing Director for Medical Aesthetics at Allergan Korea. Krishna's career began with Eli Lilly, holding multiple brand management roles in India and Australia, and also included a strategic marketing position at Actelion. Krishna holds a Bachelor of Science degree from Andhra University, completed between 1985 and 1992.
This person is not in any teams
This person is not in any offices
Teoxane Laboratories
1 followers
When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.